We are live on ! Find out more

17 hedge funds and large institutions have $1.09M invested in Imunon in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

0% less ownership

Funds ownership: 0.01%0% (-0%)

26% less funds holding

Funds holding: 2317 (-6)

28% less capital invested

Capital invested by funds: $1.51M → $1.09M (-$420K)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
17
Holders Change
-6
Holders Change %
-26.09%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
1
Closed
6
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
+$5K

IMNN Hedge Fund Activity: Q1 2017 in Review

17 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2017, worth a combined $1.09M — down 28% from $1.51M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMNN and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 6 added.

The largest buyer was BlackRock, adding an estimated $326K. The largest seller was Sabby Management, exiting entirely with an estimated $416K sold.

  • 17 institutional investors held Imunon (IMNN) as of Q1 2017, down from 23 in Q4 2016.
  • Funds reported $1.09M of Imunon stock for Q1 2017, down 28% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q1 2017 and 6 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q1 2017 was BlackRock, an estimated $326K added.
  • The largest Imunon seller in Q1 2017 was Sabby Management, an estimated $416K sold.

Based on aggregated 13F filings for Q1 2017.